Log in

Lixte Biotechnology SEC Filings & 10K Form (OTCMKTS:LIXT)

$0.99
+0.02 (+2.06 %)
(As of 02/23/2020 10:02 AM ET)
Today's Range
$0.99
Now: $0.99
$1.00
50-Day Range
$0.65
MA: $0.78
$1.00
52-Week Range
$0.57
Now: $0.99
$1.45
Volume11,050 shs
Average Volume9,005 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

SEC Filings

Lixte Biotechnology (OTCMKTS:LIXT) SEC Filings

DateFilerForm TypeView
11/08/2019
7:16 AM
Lixte Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/19/2019
2:18 PM
Lixte Biotechnology (Filer)
Form CT ORDER
08/06/2019
3:06 PM
Lixte Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
2:29 PM
Lixte Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:06 PM
Lixte Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/25/2019
3:36 PM
Lixte Biotechnology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/11/2018
8:15 PM
Lixte Biotechnology (Issuer)
Schwartzberg Gil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
7:34 PM
Lixte Biotechnology (Issuer)
Palmedo Philip F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
7:03 PM
Forman Stephen J. (Reporting)
Lixte Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
6:49 PM
Lixte Biotechnology (Issuer)
Riggs Arthur (Reporting)
Riggs Jane Merrill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
6:11 PM
GREENBERG FAMILY TRUST (Reporting)
GREENBERG M SUSAN (Reporting)
GREENBERG ROBERT (Reporting)
Lixte Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2018
4:29 PM
Lixte Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2018
2:50 PM
Lixte Biotechnology (Filer)
Form CT ORDER
08/23/2018
3:22 PM
Lixte Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
7:43 PM
Ho Sze Chun Winson (Reporting)
Lixte Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2018
7:27 PM
Lixte Biotechnology (Issuer)
Yen Yun (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2018
2:37 PM
Lixte Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
3:06 PM
Lixte Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/23/2018
3:06 PM
Lixte Biotechnology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel